Global Pneumococcal Vaccines Market Research Report 2025(Status and Outlook)
Description
Report Overview
The pneumococcal vaccine market is a critical segment within the global healthcare industry, focused on preventing infections caused by *Streptococcus pneumoniae*, a bacterium responsible for diseases such as pneumonia, meningitis, and sepsis. These vaccines are categorized into two main types: pneumococcal conjugate vaccines (PCVs), which are highly effective in infants and young children, and pneumococcal polysaccharide vaccines (PPSVs), primarily used for adults and immunocompromised individuals.
The market is driven by increasing awareness of vaccine-preventable diseases, rising geriatric populations susceptible to pneumococcal infections, and government immunization programs in both developed and emerging economies. Key players, including Pfizer (Prevnar 13), Merck (Pneumovax 23), and GlaxoSmithKline, dominate the sector, with ongoing R&D efforts to expand serotype coverage and improve efficacy.
Challenges include high production costs, logistical hurdles in low-income regions, and vaccine hesitancy in certain demographics. However, growing healthcare expenditure, advancements in biotechnology, and expanding pediatric vaccination schedules in countries like India and China present significant growth opportunities. Regulatory approvals, such as the WHO’s prequalification of newer vaccines, further accelerate market penetration in underserved regions.
The global Pneumococcal Vaccines market size was estimated at USD 7369.91 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 1.11% during the forecast period.
This report provides a deep insight into the global Pneumococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Vaccines market in any manner.
Global Pneumococcal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
Market Segmentation (by Type)
PPSV 23
PCV 7/13
PCV 10
Market Segmentation (by Application)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (Above 65)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pneumococcal Vaccines Market
Overview of the regional outlook of the Pneumococcal Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pneumococcal Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The pneumococcal vaccine market is a critical segment within the global healthcare industry, focused on preventing infections caused by *Streptococcus pneumoniae*, a bacterium responsible for diseases such as pneumonia, meningitis, and sepsis. These vaccines are categorized into two main types: pneumococcal conjugate vaccines (PCVs), which are highly effective in infants and young children, and pneumococcal polysaccharide vaccines (PPSVs), primarily used for adults and immunocompromised individuals.
The market is driven by increasing awareness of vaccine-preventable diseases, rising geriatric populations susceptible to pneumococcal infections, and government immunization programs in both developed and emerging economies. Key players, including Pfizer (Prevnar 13), Merck (Pneumovax 23), and GlaxoSmithKline, dominate the sector, with ongoing R&D efforts to expand serotype coverage and improve efficacy.
Challenges include high production costs, logistical hurdles in low-income regions, and vaccine hesitancy in certain demographics. However, growing healthcare expenditure, advancements in biotechnology, and expanding pediatric vaccination schedules in countries like India and China present significant growth opportunities. Regulatory approvals, such as the WHO’s prequalification of newer vaccines, further accelerate market penetration in underserved regions.
The global Pneumococcal Vaccines market size was estimated at USD 7369.91 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 1.11% during the forecast period.
This report provides a deep insight into the global Pneumococcal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Vaccines market in any manner.
Global Pneumococcal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
Market Segmentation (by Type)
PPSV 23
PCV 7/13
PCV 10
Market Segmentation (by Application)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (Above 65)
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Pneumococcal Vaccines Market
Overview of the regional outlook of the Pneumococcal Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Pneumococcal Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
171 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Pneumococcal Vaccines
- 1.2 Key Market Segments
- 1.2.1 Pneumococcal Vaccines Segment By Type
- 1.2.2 Pneumococcal Vaccines Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Pneumococcal Vaccines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Pneumococcal Vaccines Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Pneumococcal Vaccines Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Pneumococcal Vaccines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Pneumococcal Vaccines Product Life Cycle
- 3.3 Global Pneumococcal Vaccines Sales By Manufacturers (2020-2025)
- 3.4 Global Pneumococcal Vaccines Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Pneumococcal Vaccines Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Pneumococcal Vaccines Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Pneumococcal Vaccines Market Competitive Situation And Trends
- 3.8.1 Pneumococcal Vaccines Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Pneumococcal Vaccines Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Pneumococcal Vaccines Industry Chain Analysis
- 4.1 Pneumococcal Vaccines Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Pneumococcal Vaccines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Pneumococcal Vaccines Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Pneumococcal Vaccines Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Pneumococcal Vaccines Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Pneumococcal Vaccines Sales Market Share By Type (2020-2025)
- 6.3 Global Pneumococcal Vaccines Market Size Market Share By Type (2020-2025)
- 6.4 Global Pneumococcal Vaccines Price By Type (2020-2025)
- 7 Pneumococcal Vaccines Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Pneumococcal Vaccines Market Sales By Application (2020-2025)
- 7.3 Global Pneumococcal Vaccines Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Pneumococcal Vaccines Sales Growth Rate By Application (2020-2025)
- 8 Pneumococcal Vaccines Market Sales By Region
- 8.1 Global Pneumococcal Vaccines Sales By Region
- 8.1.1 Global Pneumococcal Vaccines Sales By Region
- 8.1.2 Global Pneumococcal Vaccines Sales Market Share By Region
- 8.2 Global Pneumococcal Vaccines Market Size By Region
- 8.2.1 Global Pneumococcal Vaccines Market Size By Region
- 8.2.2 Global Pneumococcal Vaccines Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Pneumococcal Vaccines Sales By Country
- 8.3.2 North America Pneumococcal Vaccines Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Pneumococcal Vaccines Sales By Country
- 8.4.2 Europe Pneumococcal Vaccines Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Pneumococcal Vaccines Sales By Region
- 8.5.2 Asia Pacific Pneumococcal Vaccines Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Pneumococcal Vaccines Sales By Country
- 8.6.2 South America Pneumococcal Vaccines Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Pneumococcal Vaccines Sales By Region
- 8.7.2 Middle East And Africa Pneumococcal Vaccines Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Pneumococcal Vaccines Market Production By Region
- 9.1 Global Production Of Pneumococcal Vaccines By Region(2020-2025)
- 9.2 Global Pneumococcal Vaccines Revenue Market Share By Region (2020-2025)
- 9.3 Global Pneumococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Pneumococcal Vaccines Production
- 9.4.1 North America Pneumococcal Vaccines Production Growth Rate (2020-2025)
- 9.4.2 North America Pneumococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Pneumococcal Vaccines Production
- 9.5.1 Europe Pneumococcal Vaccines Production Growth Rate (2020-2025)
- 9.5.2 Europe Pneumococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Pneumococcal Vaccines Production (2020-2025)
- 9.6.1 Japan Pneumococcal Vaccines Production Growth Rate (2020-2025)
- 9.6.2 Japan Pneumococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Pneumococcal Vaccines Production (2020-2025)
- 9.7.1 China Pneumococcal Vaccines Production Growth Rate (2020-2025)
- 9.7.2 China Pneumococcal Vaccines Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Pfizer
- 10.1.1 Pfizer Basic Information
- 10.1.2 Pfizer Pneumococcal Vaccines Product Overview
- 10.1.3 Pfizer Pneumococcal Vaccines Product Market Performance
- 10.1.4 Pfizer Business Overview
- 10.1.5 Pfizer Swot Analysis
- 10.1.6 Pfizer Recent Developments
- 10.2 Sanofi
- 10.2.1 Sanofi Basic Information
- 10.2.2 Sanofi Pneumococcal Vaccines Product Overview
- 10.2.3 Sanofi Pneumococcal Vaccines Product Market Performance
- 10.2.4 Sanofi Business Overview
- 10.2.5 Sanofi Swot Analysis
- 10.2.6 Sanofi Recent Developments
- 10.3 Gsk
- 10.3.1 Gsk Basic Information
- 10.3.2 Gsk Pneumococcal Vaccines Product Overview
- 10.3.3 Gsk Pneumococcal Vaccines Product Market Performance
- 10.3.4 Gsk Business Overview
- 10.3.5 Gsk Swot Analysis
- 10.3.6 Gsk Recent Developments
- 10.4 Merck
- 10.4.1 Merck Basic Information
- 10.4.2 Merck Pneumococcal Vaccines Product Overview
- 10.4.3 Merck Pneumococcal Vaccines Product Market Performance
- 10.4.4 Merck Business Overview
- 10.4.5 Merck Recent Developments
- 10.5 Eli Lilly
- 10.5.1 Eli Lilly Basic Information
- 10.5.2 Eli Lilly Pneumococcal Vaccines Product Overview
- 10.5.3 Eli Lilly Pneumococcal Vaccines Product Market Performance
- 10.5.4 Eli Lilly Business Overview
- 10.5.5 Eli Lilly Recent Developments
- 10.6 Astrazeneca
- 10.6.1 Astrazeneca Basic Information
- 10.6.2 Astrazeneca Pneumococcal Vaccines Product Overview
- 10.6.3 Astrazeneca Pneumococcal Vaccines Product Market Performance
- 10.6.4 Astrazeneca Business Overview
- 10.6.5 Astrazeneca Recent Developments
- 10.7 Abera
- 10.7.1 Abera Basic Information
- 10.7.2 Abera Pneumococcal Vaccines Product Overview
- 10.7.3 Abera Pneumococcal Vaccines Product Market Performance
- 10.7.4 Abera Business Overview
- 10.7.5 Abera Recent Developments
- 10.8 S K Chemicals
- 10.8.1 S K Chemicals Basic Information
- 10.8.2 S K Chemicals Pneumococcal Vaccines Product Overview
- 10.8.3 S K Chemicals Pneumococcal Vaccines Product Market Performance
- 10.8.4 S K Chemicals Business Overview
- 10.8.5 S K Chemicals Recent Developments
- 10.9 Beijing Minhai Biotechnology
- 10.9.1 Beijing Minhai Biotechnology Basic Information
- 10.9.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Overview
- 10.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Market Performance
- 10.9.4 Beijing Minhai Biotechnology Business Overview
- 10.9.5 Beijing Minhai Biotechnology Recent Developments
- 10.10 Baxter
- 10.10.1 Baxter Basic Information
- 10.10.2 Baxter Pneumococcal Vaccines Product Overview
- 10.10.3 Baxter Pneumococcal Vaccines Product Market Performance
- 10.10.4 Baxter Business Overview
- 10.10.5 Baxter Recent Developments
- 10.11 Biken
- 10.11.1 Biken Basic Information
- 10.11.2 Biken Pneumococcal Vaccines Product Overview
- 10.11.3 Biken Pneumococcal Vaccines Product Market Performance
- 10.11.4 Biken Business Overview
- 10.11.5 Biken Recent Developments
- 10.12 Celgene Corporation
- 10.12.1 Celgene Corporation Basic Information
- 10.12.2 Celgene Corporation Pneumococcal Vaccines Product Overview
- 10.12.3 Celgene Corporation Pneumococcal Vaccines Product Market Performance
- 10.12.4 Celgene Corporation Business Overview
- 10.12.5 Celgene Corporation Recent Developments
- 10.13 Panacea Biotec
- 10.13.1 Panacea Biotec Basic Information
- 10.13.2 Panacea Biotec Pneumococcal Vaccines Product Overview
- 10.13.3 Panacea Biotec Pneumococcal Vaccines Product Market Performance
- 10.13.4 Panacea Biotec Business Overview
- 10.13.5 Panacea Biotec Recent Developments
- 10.14 Serum Institute Of India
- 10.14.1 Serum Institute Of India Basic Information
- 10.14.2 Serum Institute Of India Pneumococcal Vaccines Product Overview
- 10.14.3 Serum Institute Of India Pneumococcal Vaccines Product Market Performance
- 10.14.4 Serum Institute Of India Business Overview
- 10.14.5 Serum Institute Of India Recent Developments
- 10.15 Genentech
- 10.15.1 Genentech Basic Information
- 10.15.2 Genentech Pneumococcal Vaccines Product Overview
- 10.15.3 Genentech Pneumococcal Vaccines Product Market Performance
- 10.15.4 Genentech Business Overview
- 10.15.5 Genentech Recent Developments
- 10.16 Genocea Biosciences
- 10.16.1 Genocea Biosciences Basic Information
- 10.16.2 Genocea Biosciences Pneumococcal Vaccines Product Overview
- 10.16.3 Genocea Biosciences Pneumococcal Vaccines Product Market Performance
- 10.16.4 Genocea Biosciences Business Overview
- 10.16.5 Genocea Biosciences Recent Developments
- 10.17 Immunobiology
- 10.17.1 Immunobiology Basic Information
- 10.17.2 Immunobiology Pneumococcal Vaccines Product Overview
- 10.17.3 Immunobiology Pneumococcal Vaccines Product Market Performance
- 10.17.4 Immunobiology Business Overview
- 10.17.5 Immunobiology Recent Developments
- 10.18 Lupin
- 10.18.1 Lupin Basic Information
- 10.18.2 Lupin Pneumococcal Vaccines Product Overview
- 10.18.3 Lupin Pneumococcal Vaccines Product Market Performance
- 10.18.4 Lupin Business Overview
- 10.18.5 Lupin Recent Developments
- 10.19 Nuron Biotech
- 10.19.1 Nuron Biotech Basic Information
- 10.19.2 Nuron Biotech Pneumococcal Vaccines Product Overview
- 10.19.3 Nuron Biotech Pneumococcal Vaccines Product Market Performance
- 10.19.4 Nuron Biotech Business Overview
- 10.19.5 Nuron Biotech Recent Developments
- 10.20 Biogen
- 10.20.1 Biogen Basic Information
- 10.20.2 Biogen Pneumococcal Vaccines Product Overview
- 10.20.3 Biogen Pneumococcal Vaccines Product Market Performance
- 10.20.4 Biogen Business Overview
- 10.20.5 Biogen Recent Developments
- 10.21 Valneva Austria
- 10.21.1 Valneva Austria Basic Information
- 10.21.2 Valneva Austria Pneumococcal Vaccines Product Overview
- 10.21.3 Valneva Austria Pneumococcal Vaccines Product Market Performance
- 10.21.4 Valneva Austria Business Overview
- 10.21.5 Valneva Austria Recent Developments
- 10.22 Sinovac
- 10.22.1 Sinovac Basic Information
- 10.22.2 Sinovac Pneumococcal Vaccines Product Overview
- 10.22.3 Sinovac Pneumococcal Vaccines Product Market Performance
- 10.22.4 Sinovac Business Overview
- 10.22.5 Sinovac Recent Developments
- 11 Pneumococcal Vaccines Market Forecast By Region
- 11.1 Global Pneumococcal Vaccines Market Size Forecast
- 11.2 Global Pneumococcal Vaccines Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Pneumococcal Vaccines Market Size Forecast By Country
- 11.2.3 Asia Pacific Pneumococcal Vaccines Market Size Forecast By Region
- 11.2.4 South America Pneumococcal Vaccines Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Pneumococcal Vaccines By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Pneumococcal Vaccines Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Pneumococcal Vaccines By Type (2026-2033)
- 12.1.2 Global Pneumococcal Vaccines Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Pneumococcal Vaccines By Type (2026-2033)
- 12.2 Global Pneumococcal Vaccines Market Forecast By Application (2026-2033)
- 12.2.1 Global Pneumococcal Vaccines Sales (K Mt) Forecast By Application
- 12.2.2 Global Pneumococcal Vaccines Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
